MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1137.75%
Quick Ratio
1137.75%
Cash Ratio
230.31%
Debt to Asset Ratio
39.72%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Liability related to the sale of...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
815,435
440,939
383,745
217,442
Marketable securities
3,122,534
1,467,145
1,641,934
1,714,066
Prepaid expenses and other current assets
90,369
59,829
49,358
45,981
Total current assets
4,028,338
1,967,913
2,075,037
1,977,489
Property and equipment, gross
67,446
62,156
61,707
59,940
Less accumulated depreciation
32,838
30,681
28,513
27,014
Property and equipment, net
34,608
31,475
33,194
32,926
Operating lease right-of-use asset
127,844
129,895
132,084
134,450
Intangible assets, net
55,800
55,800
55,800
55,869
Goodwill
14,608
14,608
14,608
14,608
Restricted cash
4,858
4,858
4,858
4,858
Long-term deposits
42,454
34,709
24,148
16,851
Other noncurrent assets
14,760
14,479
14,779
14,869
Total assets
4,323,270
2,253,737
2,354,508
2,251,920
Accounts payable
88,419
80,538
64,616
74,849
Accrued expenses and other current liabilities
248,889
192,451
209,340
154,447
Operating lease liability, current
16,753
16,610
16,468
16,326
Total current liabilities
354,061
289,599
290,424
245,622
Deferred tax liability
2,353
2,353
2,353
2,353
Operating lease liability, noncurrent
137,741
140,019
142,234
142,135
Liability related to the sale of future royalties
548,542
280,643
268,446
256,509
Convertible senior notes, noncurrent
487,434
-
-
-
Warrant liability
185,253
34,327
18,546
5,918
Other noncurrent liabilities
1,648
6,879
1,208
2,479
Total liabilities
1,717,032
753,820
723,211
655,016
Common stock, 0.0001 par value 300,000,000 shares authorized as of june 30, 2026 and december 31, 2025 214,242,688 and 197,001,401 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
21
19
19
18
Additional paid-in capital
6,579,456
4,823,438
4,497,143
4,097,980
Accumulated other comprehensive income (loss)
-5,950
-622
3,237
3,116
Accumulated deficit
-3,967,289
-3,322,918
-2,869,102
-2,504,210
Total stockholders' equity
2,606,238
1,499,917
1,631,297
1,596,904
Total liabilities and stockholders' equity
4,323,270
2,253,737
2,354,508
2,251,920
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$3,122,534K (80.00%↑ Y/Y)Cash and cashequivalents$815,435K (102.62%↑ Y/Y)Prepaid expenses andother current assets$90,369K (130.13%↑ Y/Y)Property and equipment,gross$67,446K (16.13%↑ Y/Y)Total current assets$4,028,338K (85.09%↑ Y/Y)Operating leaseright-of-use asset$127,844K (12.14%↑ Y/Y)Intangible assets, net$55,800K (-0.60%↓ Y/Y)Long-term deposits$42,454K Property and equipment,net$34,608K (4.72%↑ Y/Y)Other noncurrentassets$14,760K (-53.02%↓ Y/Y)Goodwill$14,608K (0.00%↑ Y/Y)Restricted cash$4,858K (24.06%↑ Y/Y)Less accumulateddepreciation$32,838K (31.21%↑ Y/Y)Total assets$4,323,270K (77.94%↑ Y/Y)Total liabilities andstockholders' equity$4,323,270K (77.94%↑ Y/Y)Total stockholders'equity$2,606,238K (39.72%↑ Y/Y)Total liabilities$1,717,032K (204.33%↑ Y/Y)Accumulated deficit-$3,967,289K (-80.41%↓ Y/Y)Accumulated othercomprehensive income (loss)-$5,950K (-556.99%↓ Y/Y)Additional paid-in capital$6,579,456K (61.93%↑ Y/Y)Liability related to thesale of future...$548,542K (123.82%↑ Y/Y)Convertible senior notes,noncurrent$487,434K Total currentliabilities$354,061K (91.87%↑ Y/Y)Warrant liability$185,253K (3376.97%↑ Y/Y)Operating leaseliability, noncurrent$137,741K (15.07%↑ Y/Y)Deferred tax liability$2,353K (0.00%↑ Y/Y)Other noncurrentliabilities$1,648K (-77.12%↓ Y/Y)Common stock, 0.0001par value...$21K (16.67%↑ Y/Y)Accrued expenses andother current...$248,889K (117.02%↑ Y/Y)Accounts payable$88,419K (55.77%↑ Y/Y)Operating leaseliability, current$16,753K (28.00%↑ Y/Y)

Revolution Medicines, Inc. (RVMD)

Revolution Medicines, Inc. (RVMD)